seed
Stage
2024
Founded
1
Investors
About
Nilo Therapeutics develops drugs targeting neural circuits that modulate immune responses to treat immune disorders including toxic shock, cytokine storms, rheumatoid arthritis, and other autoimmune diseases.
Explore Nilo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.